XML 70 R38.htm IDEA: XBRL DOCUMENT v3.19.1
Share-Based Payments (Tables)
 3 Months Ended
Mar. 31, 2019
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Share-based compensation expense included in condensed consolidated statements of income
The following table summarizes share-based compensation expense included in our condensed consolidated statements of income:
 
For the Three Months
Ended March 31,
(In millions)
2019
 
2018
Research and development
$
21.7

 
$
21.9

Selling, general and administrative
27.8

 
28.5

Subtotal
49.5

 
50.4

Capitalized share-based compensation costs
(3.3
)
 
(3.4
)
Share-based compensation expense included in total cost and expenses
46.2

 
47.0

Income tax effect
(7.4
)
 
(7.6
)
Share-based compensation expense included in net income attributable to Biogen Inc.
$
38.8

 
$
39.4
Summary of share-based compensation expense associated with each of our share-based compensating programs
The following table summarizes share-based compensation expense associated with each of our share-based compensation programs:
 
For the Three Months
Ended March 31,
(In millions)
2019
 
2018
Market stock units
$
7.7

 
$
6.1

Time-vested restricted stock units
34.7

 
36.1

Cash settled performance units
(1.0
)
 
4.3

Performance units
0.5

 
(0.8
)
Performance stock units settled in stock
2.0

 
0.7

Performance stock units settled in cash
1.0

 
0.1

Employee stock purchase plan
4.6

 
3.9

Subtotal
49.5

 
50.4

Capitalized share-based compensation costs
(3.3
)
 
(3.4
)
Share-based compensation expense included in total cost and expenses
$
46.2

 
$
47.0